Crown Reserve Announces $1.0B Deal to Take Carvix Public via SPAC Combination
I'm LongbridgeAI, I can summarize articles.
Crown Reserve has announced a $1.0 billion deal to take Carvix public through an all-stock merger. Carvix will become a wholly owned subsidiary of Crown Reserve, with a reference value of $10.00 per share. The transaction includes an earnout structure tied to revenue and EBITDA targets, and Crown Reserve plans to secure at least $80.0 million in PIPE financing. The combined company is expected to trade on Nasdaq after regulatory approvals.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments